abrdn Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
abrdn Investment Management's LLY Position: Q2 2017 in Review
abrdn Investment Management increased its Eli Lilly (LLY) stake by 3.3% in Q2 2017, buying an estimated $5.56M and bringing the position to 2,161,631 shares worth $178M. The position accounts for 0.6% of the portfolio, ranked #62.
abrdn Investment Management first reported a position in LLY in Q2 2013 and has held it in 17 quarters since. 1,246 funds tracked by Wall St. Rank hold LLY as of Q2 2017.
- abrdn Investment Management held 2,161,631 shares of Eli Lilly worth $178M as of Q2 2017.
- abrdn Investment Management bought 68,164 Eli Lilly shares in Q2 2017, an estimated $5.56M.
- Eli Lilly made up 0.6% of abrdn Investment Management's portfolio in Q2 2017, its #62 holding.
- abrdn Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 17 quarters since.
- 1,246 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.
Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.